Skip to main content
. 2011 Sep 21;6(3):167–175. doi: 10.1111/j.1750-2659.2011.00288.x

Table 2.

 Cost, effectiveness, and incremental cost‐effectiveness ratio (ICER; cost per QALY) of switching from annual to universal vaccine when universal vaccine provides 5 years of protection (50% symptomatic influenza rate)

Annual vaccine compliance Vaccination strategy Cost Effectiveness ICER
Vaccine cost $100
 Vaccine efficacy 75%
  100% Universal 1580–2120 25·52–28·29 Universal dominates
Annual 1684–2385 25·52–28·29
  75% Universal 1579–2118 25·53–28·29 Universal dominates
Annual 1649–2560 25·52–28·29
  50% Universal 1579–2120 25·52–28·29 Universal dominates
Annual 1616–2320 25·52–28·28
  25% Universal 1577–2118 25·53–28·29 Universal dominates
Annual 1578–2286 25·52–28·28
 Vaccine efficacy 50%
  100% Universal 1775–2473 25·52–28·29 Annual dominates
Annual 1685–2387 25·52–28·30
  75% Universal 1777–2474 25·53–28·29  39 482–52 197
Annual 1650–2351 25·53–28·29
  50% Universal 1775–2475 25·53–28·29  31 544–74 353
Annual 1612–2320 25·53–28·29
  25% Universal 1775–2474 25·53–28·29  33 987–49 354
Annual 1579–2282 25·52–28·29
Vaccine cost $200
 Vaccine efficacy 75%
  100% Universal 2019–2718 25·52–28·30  77 108–124 575
Annual 1684–2384 25·53–28·29
  75% Universal 2214–2893 25·52–28·29 171 099–319 601
Annual 1648–2353 25·52–28·28
  50% Universal 2020–2717 25·53–28·29  79 422–81 349
Annual 1614–2317 25·52–28·29
  25% Universal 2018–2718 25·53–28·30  33 562–47 763
Annual 1579–2288 25·52–28·28
 Vaccine efficacy 50%
  100% Universal 2411–3072 25·53–28·29 Annual dominates
Annual 1682–2387 25·53–28·29
  75% Universal 2411–3071 25·53–28·29 Annual dominates–495 957
Annual 1650–2353 25·52–28·29
  50% Universal 2413–3073 25·52–28·29 257 930–806 958
Annual 1614–2560 25·52–28·29
  25% Universal 2412–2284 25·53–28·29 144 542–172 231
Annual 1580–3073 25·52–28·29

Bold ICER values are cost‐effective.